NDC 0641-6173-01 - Dicyclomine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6173
- Requested NDC
- 0641-6173-01
- Package NDCs from labels
- 0641-6173-01, 0641-6173-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dicyclomine Hydrochloride - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6173-01 | Dicyclomine Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | 6 | |
| 0641-6173-10 | Dicyclomine Hydrochloride | 10 in 1 CARTON | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6173-01 | ML - Milliliter | 0641-6173 | ab15b7e1-d21f-4c4b-8c68-2f96570bca38 | 1 | 2016-04-04 |
| 0641-6173-10 | ML - Milliliter | 0641-6173 | 165bccf2-7ebb-4747-b9ae-cc32f2a1916a | 1 | 2016-04-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Bryant Ranch Prepack | 1f3f4e0e-c04d-4208-8549-2bacaf547176 | 2025-10-22 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Trifluent Pharma, LLC | 56282794-5874-4220-b25c-cea4b17d19aa | 2025-09-30 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | REMEDYREPACK INC. | 8652905b-b3f1-4eed-bde8-ce507186ae9a | 2025-08-12 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | Solaris Pharma Corporation | 4237bb2e-d6dd-4e3a-baa2-85be5dc3c8f2 | 2025-07-03 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | Solaris Pharma Corporation | d46259e6-5eca-4356-bc18-815104c925cc | 2025-06-11 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Proficient Rx LP | 3b7145d7-1ba7-45c1-8202-b8fc575d5a8e | 2025-06-01 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | ATLANTIC BIOLOGICALS CORP. | 2f89e438-6a8a-917e-e063-6294a90a1c23 | 2025-05-27 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | a5864c57-d73c-45c6-8985-7a041c84ccad | 2025-03-19 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine | DICYCLOMINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 2c656550-7e5b-445f-e063-6294a90a8f52 | 2025-02-24 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Bryant Ranch Prepack | 8561b68a-c88b-4047-9fcf-2df7344543b2 | 2025-02-10 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Coupler LLC | 2d439669-5cbc-292f-e063-6394a90a7ca9 | 2025-02-03 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 87cd2a04-54d6-4022-b365-646692a42f56 | 2025-01-30 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | da0e1f63-cb90-4c2a-908f-7d81e672be10 | 2025-01-07 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 8c29140b-e181-4807-870f-28e315c6d4c4 | 2025-01-07 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b3d591ad-4eb7-4cdf-93b2-62cd479e921b | 2025-01-02 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1cebadd3-2c45-9cff-e063-6394a90aaceb | 2024-12-26 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | Somerset Therapeutics, LLC | 7ad77f59-e24a-406d-95bf-3d5c6cbc3cbe | 2024-11-05 | Warnings, Adverse reactions | 991065 CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 0590c805-537e-46d3-9500-f4942c1df2ea | 2024-10-19 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Chartwell RX, LLC | d628ac1c-404d-45eb-8aab-0e550c95ed4a | 2024-10-10 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 82832a91-d16c-3a63-e053-2a91aa0a3ffb | 2024-09-12 | Warnings, Adverse reactions | CQ903KQA31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.